EMERALD ADVISERS, LLC - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q1 2021$11,000,000
-61.7%
214,672
-53.7%
0.40%
-58.3%
Q4 2020$28,728,000
+36.1%
463,961
+20.5%
0.95%
+9.8%
Q3 2020$21,104,000
-8.7%
385,106
-4.2%
0.87%
-13.9%
Q2 2020$23,122,000
+53.6%
401,839
+7.2%
1.01%
+15.7%
Q1 2020$15,057,000
+119.8%
374,734
+116.3%
0.87%
+201.4%
Q4 2019$6,851,000173,2200.29%
Other shareholders
CHEMOCENTRYX INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 545,532$13,518,0005.54%
Integral Health Asset Management, LLC 574,029$14,224,0002.93%
HealthCor Management, L.P. 1,097,370$27,193,0002.73%
Logos Global Management LP 600,000$14,868,0002.73%
Cormorant Asset Management, LP 1,425,000$35,312,0002.67%
Altium Capital Management LP 160,000$3,965,0001.59%
Cahill Wealth Management, LLC 68,358$1,693,0001.43%
Hood River Capital Management LLC 1,336,776$33,125,0001.32%
Sofinnova Investments, Inc. 636,659$15,776,0001.31%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,000$121,100,0001.26%
View complete list of CHEMOCENTRYX INC shareholders